MNKI-85

CAS No. 1812885-57-6

MNKI-85( MNKI85 )

Catalog No. M12783 CAS No. 1812885-57-6

MNKI-85 is a potent and selective Mnk2 inhibitor with Ki of 31 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MNKI-85
  • Note
    Research use only, not for human use.
  • Brief Description
    MNKI-85 is a potent and selective Mnk2 inhibitor with Ki of 31 nM.
  • Description
    MNKI-85 is a potent and selective Mnk2 inhibitor with Ki of 31 nM, displays no inhibitory activities against Mnk1, CDK2A, CDK9T, and CDK4D; effectively inhibits the growth of AML cells that possess an M5 subtype with FLT3-internal tandem duplication mutation, a powerful pharmacologic tool in studying the Mnk2/eIF4E-mediated tumorigenic mechanism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MNKI85
  • Pathway
    MAPK/ERK Signaling
  • Target
    MNK
  • Recptor
    MNK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1812885-57-6
  • Formula Weight
    418.487
  • Molecular Formula
    C20H23FN4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-[[4-Fluoro-2-(1-methylethoxy)phenyl]amino]-N-(2-methoxyethyl)-5-methyl-thieno[2,3-d]pyrimidine-6-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Teo T, et al. Mol Pharmacol. 2015 Aug;88(2):380-9.
molnova catalog
related products
  • CGP 57380

    A cell-permeable, specific MNK1 inhibitor with IC50 of 2.2 uM.

  • EB1

    EB1 is a potent and selective MNK kinase inhibitor with inhibitory effects on MNK1 and MNK2 with IC50 values of 0.69 μM and 9.4 μM, respectively.

  • MNKI-19

    MNKI-19 is a potent and dual-specific Mnk inhibitor with Ki of 186 nM and 68 nM for Mnk1 and Mnk2, respectively.